A Phase 2, Randomized, Double-Blind, Placebo-Controlled,Parallel-Group, Multicenter, Dose Escalation and Proof-of-ConceptStudy to Evaluate the Safety and Efficacy of Razuprotafib inHospitalized Subjects With Moderate to Severe Coronavirus Disease

  • Pritzker, Marc (PI)

Project: Research project

Project Details

Description

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose Escalation and Proof-of-Concept Study to Evaluate the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Moderate to Severe Coronavirus Disease
StatusActive
Effective start/end date7/1/207/31/24

Funding

  • AERPIO PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.